Lumata Health provides a human-led, technology-driven care management platform that combines predictive analytics with hundreds of certified ophthalmic care coaches to improve treatment adherence for chronic eye diseases. The platform delivers tailored interventions and partners with physicians, payers, and pharmaceutical manufacturers to enhance clinical outcomes and patient satisfaction. Lumata has partnered with eye care providers across the U.S., including the five largest national and regional eye care networks. The company reports that its proactive model has recently demonstrated up to 800 additional vision-saving eye injections annually for every 1,000 participating patients. Lumata plans to use the new funding to meet growing demand and further enhance the data-driven technology powering its patient adherence solutions. Founded in 2017 and based in Raleigh, N.C., the company has raised $36 million to date. Lumata Health offers an Intelligent Engagement Platform and a human-led continuous care program that combines behavioral information with clinical data to deliver tailored interventions through trained ophthalmic care coaches. The platform was developed with over $2MM in support from the National Eye Institute and is almost always free to patients. Programs are reimbursable under Medicare’s Chronic Care Management billing codes and are covered by secondary, supplement, or Medicare Advantage plans. Clinics using Lumata’s services have reported a 60% reduction in delayed appointments, and the company currently contracts with more than 300,000 patients. Lumata partners with physicians, payers, and health systems to provide between-visit assistance for chronic eye diseases such as diabetic retinopathy, macular degeneration, and glaucoma. New providers can try Lumata for 90 days with no upfront costs or EMR integration required. The company has raised more than $14.8MM in grant and venture funding to date. Lumata Health operates a human-led, intelligent eye care management platform that pairs patients with experienced eye care coordinators and JCAHPO-Certified Ophthalmic Assistants and Technicians to support care between ophthalmologist visits. The platform combines clinical and psychosocial elements with data and technology to improve adherence, education, and to address barriers such as transportation, medication refills, and injection-related anxiety. Lumata currently serves thousands of patients with vision-threatening chronic eye conditions, and data shows patients supported by the platform miss an average of 30% fewer clinic appointments. Its services are almost always free to patients and are reimbursed by most payers, including Medicare and often fully covered with supplemental insurance. The company plans to use new funding to advance predictive analytics, incorporate automated patient communication pathways, and expand offerings like pre-visit intake, prior authorization assistance, and pre-operative cataract education. Lumata was founded in 2017 by ophthalmologist Stephen R. Fransen, MD, and previously received more than $2MM in research funding from the National Eye Institute.

Total raised

$33M

Funding rounds

3

Latest round

Series B

Latest activity

Mar 2025